TP53 and hepatocellular carcinoma: Moreover, mutations in the tumor suppressor p53 (TP53), WNT pathway (APC, AXIN1, CTNNB1), telomere maintenance (TERT), and epigenetic enzymes (ARID1A, ARID2, MLL4) have also been reported in HBV-mediated HCC [40,41].